ArticleThe Journal of clinical investigation2023

Glucagon-like peptide-1 receptor blockade impairs islet secretion and glucose metabolism in humans.

Andrew A Welch et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.